arsenic trioxide has been researched along with liquiritigenin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, L; Chu, X; Han, X; Li, L; Wu, Y; Wu, Z; Xue, Y; Zhang, J; Zhang, M; Zhao, Y; Zheng, B | 1 |
1 other study(ies) available for arsenic trioxide and liquiritigenin
| Article | Year |
|---|---|
Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy.
Topics: Animals; Antioxidants; Arsenic Trioxide; Autophagy; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Flavanones; Liver; Male; Mice; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |